Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer

[1]  Robert J. Gillies,et al.  Acidic pH enhances the invasive behavior of human melanoma cells , 1996, Clinical & Experimental Metastasis.

[2]  V. Lehto,et al.  Immunohistochemical demonstration of the carbonic anhydrase isoenzymes I and II in pancreatic tumours , 1995, The Histochemical Journal.

[3]  S. Chu,et al.  The aberrant expression of cytosolic carbonic anhydrase and its clinical significance in human non-small cell lung cancer. , 2002, Cancer letters.

[4]  Jan Svoboda,et al.  Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9. , 2002, Gastroenterology.

[5]  W. Sly,et al.  The expression of carbonic anhydrase II in hematological malignancies. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  A. Harris,et al.  The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer , 2002, British Journal of Cancer.

[7]  Kerry S. Smith,et al.  Carbonic Anhydrase: New Insights for an Ancient Enzyme* 210 , 2001, The Journal of Biological Chemistry.

[8]  M. Lerman,et al.  Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. , 2001, Cancer research.

[9]  A. Harris,et al.  Towards a biological staging model for operable non-small cell lung cancer. , 2001, Lung cancer.

[10]  D. Silverman,et al.  The catalytic properties of human carbonic anhydrase IX. , 2001, Biochemical and biophysical research communications.

[11]  J. Pastorek,et al.  Transmembrane carbonic anhydrase, MN/CA IX, is a potential biomarker for biliary tumours. , 2001, Journal of hepatology.

[12]  A. Harris,et al.  Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  J. Pastorek,et al.  Characterization of the MN/CA 9 promoter proximal region: a role for specificity protein (SP) and activator protein 1 (AP1) factors. , 2001, The Biochemical journal.

[14]  A. Harris,et al.  Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. , 2001, Cancer research.

[15]  R. Figlin,et al.  Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. , 2001, Cancer research.

[16]  A. Harris,et al.  Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. , 2001, Cancer research.

[17]  A. Harris,et al.  Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  G N Shah,et al.  Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Saga,et al.  Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma , 2001, British Journal of Cancer.

[20]  A. Harris,et al.  Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. , 2001, Cancer research.

[21]  V. Sukhatme,et al.  VHL tumor suppressor regulates Cl-/HCO3- exchange and Na+/H+ exchange activities in renal carcinoma cells. , 2001, Physiological genomics.

[22]  W. Sly,et al.  Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. , 2001, The American journal of pathology.

[23]  W. Sly,et al.  Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. , 2001, The American journal of pathology.

[24]  C. Supuran,et al.  Carbonic anhydrase inhibitors: sulfonamides as antitumor agents? , 2001, Bioorganic & medicinal chemistry.

[25]  F. Howe,et al.  Why are cancers acidic? A carrier-mediated diffusion model for H+ transport in the interstitial fluid. , 2001, Novartis Foundation symposium.

[26]  R. Gillies,et al.  pH and chemotherapy. , 2001, Novartis Foundation symposium.

[27]  P H Watson,et al.  Hypoxia-inducible expression of tumor-associated carbonic anhydrases. , 2000, Cancer research.

[28]  W. Sly,et al.  Expression of the Membrane-associated Carbonic Anhydrase Isozyme XII in the Human Kidney and Renal Tumors , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[29]  W. Sly,et al.  Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours , 2000, Histochemistry and Cell Biology.

[30]  Katz,et al.  Biomarkers of renal cell carcinoma. Past and future considerations. , 2000, Urologic oncology.

[31]  H. Ueno,et al.  Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer. , 2000, Hepato-gastroenterology.

[32]  E. Swenson,et al.  The distribution and physiological significance of carbonic anhydrase in vertebrate gas exchange organs. , 2000, Respiration physiology.

[33]  J. Pastorek,et al.  Human tumour-associated cell adhesion protein MN/CA IX: identification of M75 epitope and of the region mediating cell adhesion , 2000, British Journal of Cancer.

[34]  E. Stanbridge,et al.  Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia , 2000, Cancer.

[35]  W. Sly,et al.  Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  W. Sly,et al.  Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors. , 2000, The American journal of pathology.

[37]  G. Gros,et al.  Carbon dioxide transport and carbonic anhydrase in blood and muscle. , 2000, Physiological reviews.

[38]  W. Sly,et al.  The membrane carbonic anhydrases: from CO2 transport to tumor markers. , 2000, EXS.

[39]  I. M. Spencer,et al.  The roles of carbonic anhydrase in metabolism, cell growth and cancer in animals. , 2000, EXS.

[40]  A. Burny,et al.  Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. , 1999, The European respiratory journal.

[41]  J. Pastorek,et al.  Study of in vitro conditions modulating expression of MN/CA IX protein in human cell lines derived from cervical carcinoma. , 1999, Neoplasma.

[42]  S. Larson,et al.  Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  M. Wei,et al.  Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Pastorek,et al.  Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. , 1998, The American journal of pathology.

[45]  G N Shah,et al.  Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Fisher,et al.  Regulation of Proliferation-Survival Decisions during Tumor Cell Hypoxia , 1998, Molecular and Cellular Biology.

[47]  N. Delamere,et al.  Cytoplasmic pH Responses to Carbonic Anhydrase Inhibitors in Cultured Rabbit Nonpigmented Ciliary Epithelium , 1998, The Journal of Membrane Biology.

[48]  P. Vaupel,et al.  The influence of tumor blood flow and microenvironmental factors on the efficacy of radiation, drugs and localized hyperthermia , 1997, Klinische Padiatrie.

[49]  R. Odze,et al.  MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker. , 1997, Human pathology.

[50]  Adrian L. Harris,et al.  Targeting gene expression to hypoxic tumor cells , 1997, Nature Medicine.

[51]  J. Pastorek,et al.  Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. , 1997, Gastroenterology.

[52]  R. Kettmann,et al.  Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. , 1996, Genomics.

[53]  J. Schlessinger,et al.  The carbonic anhydrase domain of receptor tyrosine phosphatase β is a functional ligand for the axonal cell recognition molecule contactin , 1995, Cell.

[54]  R. Kettmann,et al.  Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. , 1994, Oncogene.

[55]  J. Pastorek,et al.  Expression of MaTu‐MN protein in human tumor cultures and in clinical specimens , 1993, International journal of cancer.

[56]  B. Teicher,et al.  A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. , 1993, Anticancer Research.

[57]  S. Frankel,et al.  Carbonic anhydrase: a marker for the erythroid phenotype in acute nonlymphocytic leukemia. , 1986, Blood.